Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease worldwide, a major cause of cardiometabolic events and, in its most advanced form, metabolic dysfunction-associated steatohepatitis (MASH), the most common cause of liver-related morbidity and mortality.

Guests:  Sarah Wheeler, Pharm.D., BCACP, CDCES and Samantha Burton, Pharm.D., MS

Music by Good Talk